为慢性髓性白血病患者建立综合护理网络:从坦桑尼亚学到的经验教训
1Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Seminars in hematology
|July 10, 2023
概括
向疗法已经改变了慢性髓性白血病 (CML) 护理,但在低收入国家仍然存在差距. 本综述分享了在坦桑尼亚建立CML护理网络的经验,以应对这些挑战.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 针对性治疗和BCR::ABL1瘤基因检测已经改善了20年来慢性髓性白血病 (CML) 护理.
- 在高收入国家中,CML已经从致命的恶性瘤转变为慢性疾病,并改善了生存率.
- 高收入国家和低收入和中等收入国家 (LMICs) 之间存在CML患者结局的显著差异.
研究的目的:
- 审查在坦桑尼亚为CML患者建立综合护理网络的经验和教训.
- 突出LMIC中CML护理的障碍,包括早期诊断,治疗准入和监测.
- 分享关于克服在资源有限的环境中提供先进的癌症护理方面的挑战的见解.
主要方法:
- 本综述综合了开发CML护理网络的实际经验.
- 它探讨了坦桑尼亚医疗保健环境中遇到的具体挑战.
- 学到的经验教训集中在实际实施和可持续性上.
主要成果:
- 坦桑尼亚全面的CML护理障碍包括诊断局限性,治疗可访问性问题和疾病监测不足.
- 建立功能性护理网络需要解决基础设施,医疗保健专业人员培训和患者支持问题.
- 成功实施涉及到协作努力和为资源有限的设置量身定制的战略.
结论:
- 尽管取得了进展,但在坦桑尼亚等LMIC中,公平的CML护理仍然是一个挑战.
- 发展可持续的,全面的护理网络对于改善CML患者的治疗结果至关重要.
- 分享坦桑尼亚的经验为全球类似举措提供了有价值的见解.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
43
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
43
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K